T1	Pharmacological_substance 0 7	Glucose
N1000 	Reference T1 MeSH:D005947	Glucose
T2	Pharmacological_substance 12 19	insulin
N1001 	Reference T2 MeSH:D007328	insulin
T5	Pharmacological_substance 131 138	insulin
N1002 	Reference T5 MeSH:D007328	insulin
T8	Pharmacological_substance 143 150	glucose
N1003 	Reference T8 MeSH:D005947	glucose
T9	Disorder 251 265	hyperglycaemia
N1 	Reference T9 UMLS:C0020456	hyperglycaemia
T10	Disorder 270 287	hyperinsulinaemia
N2 	Reference T10 UMLS:C0020459	hyperinsulinaemia
T11	Disorder 331 339	diabetic
N3 	Reference T11 UMLS:C0011860	diabetic
N4 	Reference T11 UMLS:C0011849	diabetic
T15	Pharmacological_substance 577 584	insulin
N1004 	Reference T15 MeSH:D007328	insulin
T22	Pharmacological_substance 719 731	somatostatin
N1005 	Reference T22 MeSH:D013004	somatostatin
T24	Pharmacological_substance 981 988	Insulin
N1006 	Reference T24 MeSH:D007328	Insulin
T27	Disorder 1088 1102	Hyperglycaemia
N5 	Reference T27 UMLS:C0020456	Hyperglycaemia
T28	Pharmacological_substance 1182 1189	glucose
N1007 	Reference T28 MeSH:D005947	glucose
T29	Pharmacological_substance 1194 1201	insulin
N1008 	Reference T29 MeSH:D007328	insulin
T32	Pharmacological_substance 1221 1233	somatostatin
N1009 	Reference T32 MeSH:D013004	somatostatin
T35	Pharmacological_substance 1314 1321	Glucose
N1010 	Reference T35 MeSH:D005947	Glucose
T36	Pharmacological_substance 1326 1333	insulin
N1011 	Reference T36 MeSH:D007328	insulin
T39	Disorder 1496 1504	diabetes
N6 	Reference T39 UMLS:C0011860	diabetes
N7 	Reference T39 UMLS:C0011849	diabetes
T42	Disorder 1543 1587	Type I (insulin-dependent) diabetes mellitus
N8 	Reference T42 UMLS:C0011854	Type I (insulin-dependent) diabetes mellitus
T3	Subject 434 464	healthy subjects (each, n = 9)
T4	Subject 75 89	healthy humans
T37	Pharmacological_substance 566 573	placebo
N1012 	Reference T37 MeSH:D010919	placebo
T23	Subject 1529 1537	patients
T41	Subject 340 348	patients
T52	Pharmacological_substance 352 359	insulin
N1013 	Reference T52 MeSH:D007328	insulin
T55	Combination 1238 1253	co-administered
T59	Pharmacological_substance 480 501	hyperglycaemic clamps
T14	Combination 559 565	during
T6	Disorder 35 41;52 71	ocular vasodilator effects
T7	Disorder 46 71	renal vasodilator effects
T12	Combination 26 34	additive
T16	Disorder 157 162;174 186	renal vasodilation
T17	Disorder 167 186	ocular vasodilation
T19	Speculation_cue 117 125	evidence
T20	Combination 139 142	and
